TTK (threonine tyrosine kinase) regulates the malignant behaviors of cancer cells and is regulated by microRNA-582-5p in ovarian cancer

References

• Chen SN, Chang R, Lin LT, et al. MicroRNA in Ovarian cancer: biology, pathogenesis, and therapeutic opportunities. Int J Environ Res Public Health. 2019;16:1510.
   PubMed Web of Science ®Google Scholar
• Chen Y, Du H, Bao L, et al. LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214. Cancer Biol Med. 2018;15:238–250.
   PubMed Web of Science ®Google Scholar
• Stewart C, Ralyea C, Lockwood S. Ovarian cancer: an integrated review.
   Google Scholar
• Ottevanger PB. Ovarian cancer stem cells more questions than answers. Seminars in cancer biology. 2017; 44:67–71.
   Google Scholar
• Liang H, Yu T, Han Y, et al. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression. Mol Cancer. 2018;17:119.
   PubMed Web of Science ®Google Scholar
• Musacchio A. The molecular biology of spindle assembly checkpoint signaling dynamics. Curr Biol. 2015;25:R1002–18.
   PubMed Web of Science ®Google Scholar
• Thu KL, Silvester J, Elliott MJ, et al. Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 2018; 115:E1570–e7.
   Google Scholar
• Yang Q, Yu B, Sun J. TTK, CDC25A, and ESPL1 as prognostic biomarkers for endometrial cancer. Biomed Res Int. 2020;2020:4625123.
   PubMed Web of Science ®Google Scholar
• Uitdehaag JCM, De Man J, Willemsen-Seegers N, et al. Target residence time-guided optimization on TTK kinase results in inhibitors with potent anti-proliferative activity. J Mol Biol. 2017;429:2211–2230.
   PubMed Web of Science ®Google Scholar
• Zhang H, Yao W, Zhang M, et al. TTK inhibitor promotes radiosensitivity of liver cancer cells through p21. Biochem Biophys Res Commun. 2021;550:84–91.
   PubMed Web of Science ®Google Scholar
• Liu X, Liao W, Yuan Q, et al. TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells. Oncotarget. 2015;6:34309–34320.
   PubMed Web of Science ®Google Scholar
• Tsai YM, Wu KL, Chang YY, et al. Upregulation of Thr/Tyr kinase increases the cancer progression by neurotensin and dihydropyrimidinase-like 3 in lung cancer. Int J Mol Sci. 2020;21:1640.
   PubMed Web of Science ®Google Scholar
• Chen S, Wang Y, Ni C, et al. HLF/miR-132/TTK axis regulates cell proliferation, metastasis and radiosensitivity of glioma cells. Biomed Pharmacothe. 2016;83:898–904.
   PubMed Web of Science ®Google Scholar
• Shin VY, Chu KM. MiRNA as potential biomarkers and therapeutic targets for gastric cancer. World J Gastroenterol. 2014;20:10432–10439.
   PubMed Web of Science ®Google Scholar
• Romano G, Veneziano D, Acunzo M, et al. Small non-coding RNA and cancer. Carcinogenesis. 2017;38:485–491.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang L. Members of the microRNA-200 family are promising therapeutic targets in cancer. Exp Ther Med. 2017;14:10–17.
   PubMed Web of Science ®Google Scholar
• He L, Zhu W, Chen Q, et al. Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis. Theranostics. 2019;9:8206–8220.
   PubMed Web of Science ®Google Scholar
• Zhu B, V VM, Finch-Edmondson M, et al. miR-582-5p Is a tumor suppressor microRNA targeting the Hippo-YAP/TAZ signaling pathway in non-small cell lung cancer. Cancers (Basel). 2021;13(4):756.
   PubMed Web of Science ®Google Scholar
• Zhang N, Jin Y, Hu Q, et al. Circular RNA hsa_circ_0078607 suppresses ovarian cancer progression by regulating miR-518a-5p/Fas signaling pathway. J Ovarian Res. 2020;13:64.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu R, Zhang D, et al. Circ-ZKSCAN1 regulates FAM83A expression and inactivates MAPK signaling by targeting miR-330-5p to promote non-small cell lung cancer progression. Transl Lung Cancer Res. 2019;8:862–875.
   PubMed Web of Science ®Google Scholar
• Li S, Zeng M, Yang L, et al. Hsa_circ_0008934 promotes the proliferation and migration of osteosarcoma cells by targeting miR-145-5p to enhance E2F3 expression. Int J Biochem Cell Biol. 2020;127:105826.
   PubMed Web of Science ®Google Scholar
• Chen LY, Wang L, Ren YX, et al. The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1α translation. Mol Cancer. 2020;19:164.
   PubMed Web of Science ®Google Scholar
• Jiao J, Zhang T, Jiao X, et al. hsa_circ_0000745 promotes cervical cancer by increasing cell proliferation, migration, and invasion. J Cell Physiol. 2020;235:1287–1295.
   PubMed Web of Science ®Google Scholar
• Ke KJ, Wang CY, Li P, et al. Hsa_circ_001193 regulates proliferation and apoptosis of nasopharyngeal carcinoma cells through targeting mir-496. Eur Rev Med Pharmacol Sci. 2020;24:3069–3076.
   PubMed Web of Science ®Google Scholar
• Xu L, Feng X, Hao X, et al. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth. J Exp Clin Cancer Res. 2019;38:98.
   PubMed Web of Science ®Google Scholar
• Foijer F, Xie SZ, Simon JE, et al. Chromosome instability induced by Mps1 and p53 mutation generates aggressive lymphomas exhibiting aneuploidy-induced stress. Proceedings of the National Academy of Sciences of the United States of America. 2014; 111:13427–13432.
   Google Scholar
• Chen S, Wang J, Wang L, et al. Silencing TTK expression inhibits the proliferation and progression of prostate cancer. Exp Cell Res. 2019;385:111669.
   PubMed Web of Science ®Google Scholar
• Huang H, Yang Y, Zhang W, et al. TTK regulates proliferation and apoptosis of gastric cancer cells through the Akt-mTOR pathway. FEBS Open Bio. 2020;10(8):1542–1549.
   PubMed Web of Science ®Google Scholar
• Zhang L, Jiang B, Zhu N, et al. Mitotic checkpoint kinase Mps1/TTK predicts prognosis of colon cancer patients and regulates tumor proliferation and differentiation via PKCalpha/ERK1/2 and PI3K/Akt pathway. Med Oncol. 2019;37(1):5.
   PubMed Web of Science ®Google Scholar
• Zaman GJR, de Roos JADM, Libouban MAA, et al. TTK Inhibitors as a Targeted Therapy for CTNNB1 (beta-catenin) Mutant Cancers. Mol Cancer Ther. 2017;16(11):2609–2617.
   PubMed Web of Science ®Google Scholar
• Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141:1202–1207.
   PubMed Web of Science ®Google Scholar
• Mishra S, Yadav T, Rani V. Exploring miRNA based approaches in cancer diagnostics and therapeutics. Crit Rev Oncol Hematol. 2016;98:12–23.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhu W, Tao G, et al. Circular RNA circ-LRP6 facilitates Myc-driven tumorigenesis in esophageal squamous cell cancer. Bioengineered. 2020;11:932–938.
   PubMed Web of Science ®Google Scholar
• Zhou D, Lin X, Wang P, et al. RNA circ_0001162 promotes cell proliferation and invasion of glioma via the miR-936/ERBB4 axis. Bioengineered. 2021;12:2106–2118.
   PubMed Web of Science ®Google Scholar
• Ye CY, Zheng CP, Zhou WJ, et al. MiR-582-5p inhibits the growth and invasion of osteosarcoma cell by targeting NOVA1. Eur Rev Med Pharmacol Sci. 2020;24:11026–11031.
   PubMed Web of Science ®Google Scholar
• Tian Y, Guan Y, Su Y, et al. MiR-582-5p inhibits bladder cancer-genesis by suppressing TTK expression. Cancer Manag Res. 2020;12:11933–11944.
   PubMed Web of Science ®Google Scholar
• Wang LL, Zhang M. miR-582-5p is a potential prognostic marker in human non-small cell lung cancer and functions as a tumor suppressor by targeting MAP3K2. Eur Rev Med Pharmacol Sci. 2018;22:7760–7767.
   PubMed Web of Science ®Google Scholar
• Li L, Ma L. Upregulation of miR-582-5p regulates cell proliferation and apoptosis by targeting AKT3 in human endometrial carcinoma. Saudi J Biol Sci. 2018;25:965–970.
   PubMed Web of Science ®Google Scholar